oky 025 has been researched along with thromboxane a2 in 2 studies
| Studies (oky 025) | Trials (oky 025) | Recent Studies (post-2010) (oky 025) | Studies (thromboxane a2) | Trials (thromboxane a2) | Recent Studies (post-2010) (thromboxane a2) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 5,617 | 224 | 429 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alksne, JF; Schumacher, MA | 1 |
| Ambroise-Thomas, P; Chumpitazi, BF; Peyron, F; Picot, S; Polack, B; Ricard, J; Simon, J | 1 |
2 other study(ies) available for oky 025 and thromboxane a2
| Article | Year |
|---|---|
Mechanisms of whole blood-induced cerebral arterial contraction.
Topics: Animals; Basilar Artery; Blood Coagulation; Blood Platelets; Collagen; Dose-Response Relationship, Drug; Female; Imidazoles; In Vitro Techniques; Ischemic Attack, Transient; Male; Methysergide; Models, Biological; Platelet Aggregation; Rabbits; Serotonin; Serotonin Antagonists; Subarachnoid Hemorrhage; Thromboxane A2 | 1981 |
Human platelet inhibition of Toxoplasma gondii growth.
Topics: Animals; Aspirin; Bicyclic Monoterpenes; Blood Platelets; Humans; Imidazoles; Insulin; Interleukin-6; Platelet Activation; Platelet-Derived Growth Factor; Thromboxane A2; Toxoplasma; Uracil | 1998 |